Bacterial glucuronidase as general marker for oncolytic virotherapy or other biological therapies

Bacterial glucuronidase as general marker for oncolytic virotherapy or other biological therapies

<p>Abstract</p> <p>Background</p> <p>Oncolytic viral tumor therapy is an emerging field in the fight against cancer with rising numbers of clinical trials and the first clinically approved product (Adenovirus for the treatment of Head and Neck Cancer in China) in this f...

Full description

Bibliographic Details
Main Authors: Sturm Julia B, Härtl Barbara, Stritzker Jochen, Hess Michael, Gentschev Ivaylo, Szalay Aladar A
Format: Article
Language:English
Published: BMC 2011-10-01
Series:Journal of Translational Medicine
Subjects:
beta-glucuronidase
oncolytic virus
cancer
reporter
fluorescent probe
Online Access:http://www.translational-medicine.com/content/9/1/172

Internet

http://www.translational-medicine.com/content/9/1/172

Similar Items